KALA BIO, INC. Stock Issued During Period, Shares, New Issues
KALA BIO, INC. (KALA) had Stock Issued During Period, Shares, New Issues of 565.97 thousand shares as of 2023-01-10, per its 10-Q filed 2024-05-14.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-05-14
- 2023-01-10: Stock Issued During Period, Shares, New Issues 565.97K shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2023-01-10 | 565.97K shares 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |